• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Vicarious Surgical Appoints John Mazzola as Vice President of Operations

    3/24/22 5:30:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care
    Get the next $RBOT alert in real time by email

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS))), a next-generation robotics technology company seeking to improve patient outcomes as well as the cost and efficiency of surgical procedures, today announced the appointment of John Mazzola as vice president of operations. In this new role, Mazzola will lead the strategic manufacturing plans for the Vicarious system as the company progresses development.

    Mazzola has more than 30 years of global operations and engineering management experience with leading companies in the medical device industry. Before joining Vicarious, Mazzola was a vice president of operations at Becton Dickinson Surgery. During his tenure with Becton Dickinson ("BD"), he oversaw a network of 10 manufacturing sites, a business planning and procurement organization, an advanced manufacturing engineering team, and the business' environmental health and safety responsibilities. Prior to his time at BD, Mazzola held engineering and operational roles of increasing responsibility with Bard, BD, Medtronic, and Transmedics.

    "We are excited to welcome John to our team as our vice president of operations," said Adam Sachs, CEO and co-founder of Vicarious Surgical. "John's deep operational and engineering expertise will be invaluable as we plan, develop, and execute upon our manufacturing strategies, processes, and procedures to bring next generation robotics to minimally invasive surgery."

    Mazzola continues to be active in local industry associations and currently serves as Director Emeritus for the Massachusetts Medical Device Council Board of Directors.

    "I am delighted to be joining Vicarious Surgical at such an important stage in its development," Mazzola said. "The company has a tremendous opportunity ahead to meet a substantial unmet need. I am eager to help lead efforts on the operational front to maximize Vicarious' growth potential."

    About Vicarious Surgical

    Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes, and reducing healthcare costs. The Company's novel surgical approach uses proprietary human-like surgical robots to transport surgeons inside the patient to perform minimally invasive surgery. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla's Khosla Ventures, Innovation Endeavors, Jerry Yang's AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang's E15 VC. The Company is headquartered in Waltham, Massachusetts. Learn more at www.vicarioussurgical.com.

    Source: Vicarious Surgical Inc.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220324005987/en/

    Get the next $RBOT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RBOT

    DatePrice TargetRatingAnalyst
    3/4/2022$16.00 → $7.00Overweight → Neutral
    Piper Sandler
    1/7/2022$16.00Outperform
    Credit Suisse
    12/7/2021$15.00Outperform
    Cowen & Co.
    11/5/2021$15.00Buy
    Canaccord Genuity
    10/18/2021$15.00Buy
    BTIG
    10/7/2021$16.00Overweight
    Piper Sandler
    More analyst ratings

    $RBOT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Vicarious Surgical Reports Second Quarter 2025 Financial Results

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the second quarter ended June 30, 2025. Management will host a corresponding conference call at 4:30 p.m. ET today, August 12, 2025. "Leading Vicarious Surgical from its earliest days through key development milestones has been an extraordinary experience. I'm incredibly proud of the foundation we've built. As I move into the role of President, I'm pleased to welcome Stephen as CEO," said Adam Sachs, President, Co-Founder, and Board member. "His depth of experienc

    8/12/25 4:15:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Announces Leadership Transition: Stephen From, Healthcare Industry Veteran, Appointed Chief Executive Officer

    Adam Sachs, Co-Founder, to Remain on as President Vicarious Surgical Inc. (NYSE:RBOT, RBOT WS)) (the "Company"), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the appointment of Stephen From as Chief Executive Officer and a member of the Company's Board of Directors (the "Board"), effective August 7, 2025. Adam Sachs, current Chief Executive Officer, Co-Founder, and a member of the Board, will remain with the Company as President, Co-Founder, and a member of the Board in an operational capacity as a member of the Company's leadership team. Mr. From brings over 20 years of leadership in the healthcare and financial

    7/31/25 4:30:00 PM ET
    $KPRX
    $RBOT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Specialties

    Vicarious Surgical to Report Second Quarter 2025 Financial Results on August 12, 2025

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced it will report financial results for the second quarter ended June 30, 2025 after the market closes on Tuesday, August 12, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing +1 833-470-1428 for domestic callers or +1 404-975-4839 for international callers, using access code: 572850. A live and archived webcast of the event will be available at https://inves

    7/29/25 4:05:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Ahmad Fuad

    4 - Vicarious Surgical Inc. (0001812173) (Issuer)

    8/11/25 9:04:11 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Chief Technology Officer Khalifa Sammy

    4 - Vicarious Surgical Inc. (0001812173) (Issuer)

    8/11/25 9:03:49 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Director Tang Donald F

    4 - Vicarious Surgical Inc. (0001812173) (Issuer)

    8/11/25 9:03:28 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Vicarious Surgical downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Vicarious Surgical from Overweight to Neutral and set a new price target of $7.00 from $16.00 previously

    3/4/22 4:51:18 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    Credit Suisse initiated coverage on Vicarious Surgical with a new price target

    Credit Suisse initiated coverage of Vicarious Surgical with a rating of Outperform and set a new price target of $16.00

    1/7/22 7:09:02 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    Cowen & Co. initiated coverage on Vicarious Surgical with a new price target

    Cowen & Co. initiated coverage of Vicarious Surgical with a rating of Outperform and set a new price target of $15.00

    12/7/21 7:31:51 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    SEC Filings

    View All

    SEC Form 10-Q filed by Vicarious Surgical Inc.

    10-Q - Vicarious Surgical Inc. (0001812173) (Filer)

    8/12/25 5:00:50 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Vicarious Surgical Inc. (0001812173) (Filer)

    8/12/25 4:16:02 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Vicarious Surgical Inc. (0001812173) (Filer)

    7/31/25 4:30:50 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Leadership Updates

    Live Leadership Updates

    View All

    Vicarious Surgical Announces Appointment of Sarah Romano as Chief Financial Officer

    Ms. Romano brings decades of experience with a strong track record in financial strategy and corporate development Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the appointment of Sarah Romano as Chief Financial Officer (CFO), effective April 1, 2025. Ms. Romano will oversee Vicarious Surgical's financial strategy, leveraging decades of financial leadership experience in capital markets. With exceptional strategic acumen, Ms. Romano has a proven record of driving growth and value creation in public companies, particularly in the h

    3/13/25 8:30:00 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Strengthens Executive Team with Appointment of Randy Clark as Company President

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS))), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that Randy Clark has been appointed President effective today, January 29, 2024. As Vicarious Surgical prepares for its next phase of growth following the anticipated finalization of the Vicarious Surgical Version 1.0 System ("V1.0"), the newly established role of President is designed to fortify organizational alignment and focus on the Company's long-term needs and objectives. Reporting to Chief Executive Officer Adam Sachs, Mr. Clark will a

    1/29/24 8:30:00 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Announces Changes to Board of Directors

    Victoria Carr-Brendel, Ph.D. Elected to Board of Directors Tech-Focused Venture Capitalist Phil Liang to Resign Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced the appointment of Victoria Carr-Brendel, Ph.D. to the Vicarious Surgical Board of Directors effective today, January 23, 2023. The Company also announced the resignation of technology-focused venture capitalist Phil Liang from the Vicarious Surgical Board of Directors effective as of today. "On behalf of the board, I'd like to thank Phil for his critical guidance and expertise as Vicari

    1/23/23 4:10:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Financials

    Live finance-specific insights

    View All

    Vicarious Surgical Reports Second Quarter 2025 Financial Results

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the second quarter ended June 30, 2025. Management will host a corresponding conference call at 4:30 p.m. ET today, August 12, 2025. "Leading Vicarious Surgical from its earliest days through key development milestones has been an extraordinary experience. I'm incredibly proud of the foundation we've built. As I move into the role of President, I'm pleased to welcome Stephen as CEO," said Adam Sachs, President, Co-Founder, and Board member. "His depth of experienc

    8/12/25 4:15:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical to Report Second Quarter 2025 Financial Results on August 12, 2025

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced it will report financial results for the second quarter ended June 30, 2025 after the market closes on Tuesday, August 12, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing +1 833-470-1428 for domestic callers or +1 404-975-4839 for international callers, using access code: 572850. A live and archived webcast of the event will be available at https://inves

    7/29/25 4:05:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    Vicarious Surgical Reports First Quarter 2025 Financial Results

    Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS)), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2025. Management will host a corresponding conference call at 4:30 p.m. ET today, May 12, 2025. "Following years of meticulous work to develop and advance our surgical system and proprietary decoupled actuating technology, we are just a few quarters away from our biggest milestone yet - our first clinical patients. 2025 will be the year Vicarious Surgical evolves into a clinical-stage company and demonstrates the immense value of o

    5/12/25 4:05:00 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    $RBOT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Vicarious Surgical Inc. (Amendment)

    SC 13G/A - Vicarious Surgical Inc. (0001812173) (Subject)

    2/13/24 4:36:42 PM ET
    $RBOT
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Vicarious Surgical Inc. (Amendment)

    SC 13G/A - Vicarious Surgical Inc. (0001812173) (Subject)

    8/15/23 10:28:36 AM ET
    $RBOT
    Industrial Specialties
    Health Care

    SEC Form SC 13D/A filed by Vicarious Surgical Inc. (Amendment)

    SC 13D/A - Vicarious Surgical Inc. (0001812173) (Subject)

    8/9/23 5:10:57 PM ET
    $RBOT
    Industrial Specialties
    Health Care